Register for Upcoming Webinar on DEC. 8 @ 11AM

2023 China NMPA Bluebook is here:

Market Movers: BGI’s Upcoming $250 Million China IPO


BGI Genomics is planning for its IPO in China. As the contract sequencing and diagnostics divisions of China’s genomic company BGI, BGI Genomics expects to raise $250 million from this IPO in July, following the expected final approvals from Chinese authorities. Known as a world leader in basic science sequencing, BGI Genomics now generates 55% of its income from clinical genomic tests, especially its NIFTY prenatal test for hereditary illnesses such as Down’s syndrome.

China Med Device, LLC, provides turn-key solutions for medical device medtech companies entry into China, brings you up-to-date information on China’s medical device industry. We offer market assessment, regulatory, commercialization, funding and growth acceleration services to international medtech companies. If you have any feedback, please email us at or visit us at

Have Questions?

Related Services


Recent Events

Related Posts


Get Updated

Receive Updates in Your Inbox